KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organon (OGN) Operating Income (2020 - 2026)

Organon has reported Operating Income over the past 7 years, most recently at $235.0 million for Q1 2026.

  • For Q1 2026, Operating Income fell 1.67% year-over-year to $235.0 million; the TTM value through Mar 2026 reached $1.1 billion, down 14.88%, while the annual FY2025 figure was $1.1 billion, 569.23% up from the prior year.
  • Operating Income for Q1 2026 was $235.0 million at Organon, up from $210.0 million in the prior quarter.
  • Over five years, Operating Income peaked at $411.0 million in Q3 2024 and troughed at -$579.0 million in Q4 2023.
  • A 5-year average of -$58.4 million and a median of -$119.0 million in 2022 define the central range for Operating Income.
  • Biggest five-year swings in Operating Income: tumbled 189.92% in 2023 and later surged 200.0% in 2024.
  • Year by year, Operating Income stood at -$483.0 million in 2022, then decreased by 19.88% to -$579.0 million in 2023, then skyrocketed by 149.74% to $288.0 million in 2024, then dropped by 27.08% to $210.0 million in 2025, then rose by 11.9% to $235.0 million in 2026.
  • Business Quant data shows Operating Income for OGN at $235.0 million in Q1 2026, $210.0 million in Q4 2025, and $358.0 million in Q3 2025.